Before changing at the end of 2020, I used Medtronic’s CGM for 6 years. Initially, Medtronic would replace any sensor which failed before its expected usage period. Before I changed to Dexcom, one of the things Medtronic did which irritated me was (apparently) changed that policy to only replacing a sensor which failed before the last two days of use.
I think Dexcom’s continued commitment to replacing a failed sensor is one of the reasons for their success. On the other hand, it also is no doubt expensive for Dexcom to do this. While I don’t expect Dexcom to change their position in the near future, I also wouldn’t expect it to continue unchanged forever.
My outlook on this is to wait and see what happens after the G7 is released.
Not surprisingly, that’s also my position on Medtronic. I’ll wait and see what, if anything, changes with Medtronic if they release a CGM sensor that changes from the path they’ve followed since introducing the Enlite CGM. Lord knows, they are well past time to make some changes. But that alone is no guarantee that a change for the better will happen.